Bionano Laboratories
Healthcare Services · 201-500 Employees
View Company Info for Free
Overview
Website
www.bionanolaboratories.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Bionano Laboratories
Bionano Laboratories offers genetic testing and counseling services focused on identifying the genetic causes of neurodevelopmental disorders. Their clinical services include advanced genetic testing options such as chromosomal microarray and whole exome sequencing, primarily catering to providers and researchers. They are dedicated to providing a supportive environment for families seeking answers for children with autism spectrum disorder and developmental delays. Additionally, their optical genome mapping (OGM) services support researchers in exploring structural variations in genomes.Explore more
Bionano Laboratories Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bionano Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Bionano Laboratories has new funding data
Check if Bionano Laboratories has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Bionano Laboratories launches new products
Bionano Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Bionano Laboratories is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Bionano Laboratories recently announced quarterly report
Click to see if Bionano Laboratories had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Bionano Laboratories
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bionano Laboratories
Compare insights from companies similar to Bionano Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2019
KW
Karen Walton-BowenClinical Operations, Biostatistical Analysis & Reporting Head
Company Profile Activity
Activity Insights
Bionano Laboratories is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Bionano Laboratories is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Bionano Laboratories.
Bionano Laboratories Tech Stack
A closer look at the technologies used by Bionano Laboratories
Bionano Laboratories News & Media
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders
SAN DIEGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that Centers for Medicare & Medicaid Services (CMS) posted the preliminary payment determination for the Category I Current Procedural Terminology (CPT®) code for use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variaBionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related tBionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced a publication from The University of Texas MD Anderson Cancer Center describing the largest study to-date to evaluate the clinical utility of OGM as an additional tool in the standard cytogenetic workup (SCGW) of hematologic malignancies.International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced the publication in the American Journal of Hematology of expert recommendations from the International Consortium for Optical Genome Mapping (ICOGM) for the integration of OGM as a standard-of-care (SOC) cytogenetic assay for diagnostic workflows in v
Read more news
Top Healthcare Services Companies
Frequently Asked Questions Regarding Bionano Laboratories
Sign Up For FreeTo access detailed company insights
Bionano Laboratories offers genetic testing and counseling services focused on identifying the genetic causes of neurodevelopmental disorders. Their clinical services include advanced genetic testing options such as chromosomal microarray and whole exome sequencing, primarily catering to providers and researchers. They are dedicated to providing a... Read More
